Larvol Veri

CANCER:

Gastrointestinal Stromal Tumor

KIT positive KIT positive	Gastrointestinal Stromal Tumor GIST	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1
PDGFRA D842V PDGFRA D842V	Gastrointestinal Stromal Tumor GIST	avapritinib Sensitive: A1 - Approval avapritinib Sensitive : A1
No biomarker No biomarker	Gastrointestinal Stromal Tumor GIST	sunitinib Sensitive: A1 - Approval sunitinib Sensitive : A1
No biomarker No biomarker	Gastrointestinal Stromal Tumor GIST	ripretinib Sensitive: A1 - Approval ripretinib Sensitive : A1
PDGFRA exon 18 mutation PDGFRA exon 18 mutation	Gastrointestinal Stromal Tumor GIST	avapritinib Sensitive: A1 - Approval avapritinib Sensitive : A1
No biomarker No biomarker	Gastrointestinal Stromal Tumor GIST	regorafenib Sensitive: A1 - Approval regorafenib Sensitive : A1
KIT expression KIT expression	Gastrointestinal Stromal Tumor GIST	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1
NTRK2 fusion NTRK2 fusion	Gastrointestinal Stromal Tumor GIST	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2
NTRK1 fusion NTRK1 fusion	Gastrointestinal Stromal Tumor GIST	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2
NTRK3 fusion NTRK3 fusion	Gastrointestinal Stromal Tumor GIST	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2
NTRK3 fusion NTRK3 fusion	Gastrointestinal Stromal Tumor GIST	larotrectinib Sensitive: A2 - Guideline larotrectinib Sensitive : A2
NTRK2 fusion NTRK2 fusion	Gastrointestinal Stromal Tumor GIST	larotrectinib Sensitive: A2 - Guideline larotrectinib Sensitive : A2
NTRK1 fusion NTRK1 fusion	Gastrointestinal Stromal Tumor GIST	larotrectinib Sensitive: A2 - Guideline larotrectinib Sensitive : A2
No biomarker No biomarker	Gastrointestinal Stromal Tumor GIST	cabozantinib tablet Sensitive: A2 - Guideline cabozantinib tablet Sensitive : A2
PDGFRA exon 18 mutation PDGFRA exon 18 mutation	Gastrointestinal Stromal Tumor GIST	imatinib Sensitive: A2 - Guideline imatinib Sensitive : A2
No biomarker No biomarker	Gastrointestinal Stromal Tumor GIST	imatinib Sensitive: A2 - Guideline imatinib Sensitive : A2
PDGFRA D842V PDGFRA D842V	Gastrointestinal Stromal Tumor GIST	dasatinib Sensitive: A2 - Guideline dasatinib Sensitive : A2
No biomarker No biomarker	Gastrointestinal Stromal Tumor GIST	sorafenib Sensitive: A2 - Guideline sorafenib Sensitive : A2
No biomarker No biomarker	Gastrointestinal Stromal Tumor GIST	pazopanib Sensitive: A2 - Guideline pazopanib Sensitive : A2
No biomarker No biomarker	Gastrointestinal Stromal Tumor GIST	nilotinib Sensitive: A2 - Guideline nilotinib Sensitive : A2
KIT mutation KIT mutation	Gastrointestinal Stromal Tumor GIST	ripretinib Sensitive: B - Late Trials ripretinib Sensitive : B
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	ripretinib Sensitive: B - Late Trials ripretinib Sensitive : B
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	avapritinib Sensitive: C2 – Inclusion Criteria avapritinib Sensitive : C2
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	imatinib Sensitive: C2 – Inclusion Criteria imatinib Sensitive : C2

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

ACCEPT COOKIES

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

ACCEPT COOKIES

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

ACCEPT COOKIES